SCHEMBL28299141

SCHEMBL28299141

COCCOCCN1CCOC(CNc2ccccc2[N+](=O)[O-])C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2D6 P10635 1/20 0.40
DRD4 P21917 3/20 0.39
ALDH1A1 P00352 7/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 8/20 0.38
HTT P42858 3/20 0.38
POLB P06746 1/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28151931 0.94 ALOX12 (0.43) ALOX12CYP1A2CYP2C19CYP2D6DRD4
SCHEMBL2827258 0.85 KMT2A (0.49) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL1809918 0.85 KMT2A (0.49) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL28153058 0.83 ALOX12 (0.43) ALOX12CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL1700636 0.79 KMT2A (0.52) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL28199087 0.78 MAPT (0.44) ALOX12CYP1A2CYP2C19DRD4ALDH1A1
SCHEMBL28198466 0.78 MAPT (0.41) ALOX12CYP1A2CYP2C19DRD4ALDH1A1
SCHEMBL28299139 0.78 CYP2D6 (0.42) CYP1A2CYP2C19CYP2D6DRD4ALDH1A1
SCHEMBL21331185 0.76 ALOX12 (0.47) ALOX12CYP1A2CYP2C19ALDH1A1L3MBTL1
SCHEMBL1952422 0.76 MAPT (0.40) CYP1A2CYP2C19ALDH1A1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109966294-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维爱尔兰无限公司 2019-07-05 CN disclosed
CN-109897038-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维爱尔兰无限公司 2019-06-18 CN disclosed